Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Brian Malloy who wrote (949)	4/3/1998 3:10:00 PM
From: Uncle Frank	Read Replies (3) \| Respond to of 9523

I just joined your Pfizer party today, with a cost basis of 100. Being in the appropriate age group to appreciate the potential of Viagra, I couldn't resist investing in what might prove to be the top selling drug of all time. Most of my investments are in the electronics field, though I do hold some Onyx Pharmaceutical, a research company doing some fascinating work in an innovative cancer cure (see techstocks.com. I am grateful to you all for your earlier postings, which helped me better understand PFE, and will look forward your continued postings, particularly on technical issues. I must caution you to expect a short term dip in PFE's value; I always seem to buy during a rally :-(. Frank

To: Brian Malloy who wrote (949)	4/3/1998 3:56:00 PM
From: Perry	Respond to of 9523

<<As the link below shows, even small companies in the ED market can test their products utilizing large numbers. The following is for MUSE produced by VIVUS (VVUS)>> I never claimed that a small company couldn't test their drug on large numbers of people. In fact I would expect them to do so before receving FDA approval. My comment was directed to a specific ED drug that was brought to this thread's attention (see previous post). Like I said before I don't expect PFE to take 100% of the market and in fact PFe claims that their drug is effective in ~70% of the patients tested. Therefore there's at least 30% ED patients that will need alternative treatments. All that being said, my money is still with PFE. They have the size to aggresively market this drug to physicians and their drug unlike many others works when the individual is stimulated. Thus it is a much more natural process. Good luck, Perry